KIMIABL logo

Kimia Biosciences Ltd

KIMIABL·BSE·
29.27 +0.77 (+2.70%)
Market Cap136.36 Cr
PE Ratio14.42
Volume2,673
Day High - Low29.50 - 29.00
52W High-Low43.28 - 23.20
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
53.70%
Strong
P/E
14.42x
Cheap
Debt / Equity
1.94
High
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

Day29.00
29.50
52W23.20
43.28
DocStoX take

Supported by valuation (6.3), but held back by momentum (2.2).

DocStoX score

Low confidence
4.3
/10
Weak
Quality
Solid
ROE 53.7%
Valuation
Fair
P/E 14.4×
Growth
Slow
Revenue -2.9% 5Y CAGR
Risk
High risk
D/E 1.94
Momentum
Weak
30% of 52-week range

At a glance

Market Cap
₹136 Cr
52W High / Low
₹43 / ₹23
Dividend Yield
0.00%
Promoter Holding
74.94%
EPS (TTM)
₹2.03
Book Value
₹3.75

Key highlights

  • Strong returns on equity (54%)
  • Capital works hard — ROCE 42%
  • Undemanding at 14× earnings
  • Revenue shrinking 3% a year
  • High leverage — debt is 1.9× equity
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Kimia Biosciences Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.